Clinical Trial Update: Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial investigating CM4620 to reduce severity of acute pancreatitis caused by asparaginase in pediatric patients; Phase 1/2, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatitis

Drugs mentioned

• CM4620

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Acute Pancreatitis | Phase 1, Phase 2 | Status: RECRUITING